Lori A. Ehrlich - Publications

US Food and Drug Administration Approval Summary: Imetelstat for Selected Patients With Low- to Intermediate-1 Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 24, 2025

Advancing drug development in myelodysplastic syndromes.

Journal: Blood advances

Published: September 20, 2024

An Overview of Myeloid Blast-Phase Chronic Myeloid Leukemia.

Journal: Cancers

Published: September 17, 2024

FDA Approval Summary: Asciminib for Ph+ CML in Chronic Phase Treated with Two or More Tyrosine Kinase Inhibitors and for the T315I Mutation.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 10, 2024

Project Confirm: Accelerated Drug Approvals for CML-Response.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 20, 2023

The Impact of Improved Treatments on Survival of Adult U.S. Leukemia Patients: 1990-2018.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: November 07, 2022

Considerations for Drug Development in Myelodysplastic Syndromes.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 28, 2022

Project Confirm: Accelerated Drug Approvals for Chronic Myeloid Leukemia.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 23, 2022

FDA Approval Summary: Decitabine and Cedazuridine Tablets for Myelodysplastic Syndromes.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 22, 2021

Accelerating the Global Development of Pediatric Cancer Drugs: A Call to Coordinate the Submissions of Pediatric Investigation Plans and Pediatric Study Plans to the European Medicines Agency and US Food and Drug Administration.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 18, 2020

U.S. Food and Drug Administration approval summary: Eltrombopag for the treatment of pediatric patients with chronic immune (idiopathic) thrombocytopenia.

Journal: Pediatric blood & cancer

Published: October 31, 2016

The Majority of Expedited Investigational New Drug Safety Reports Are Uninformative.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 23, 2015